A unique case of thioridazine-dependent discoloration of vision or “chromatopsia” is presented. This case merits its unique status because of the particular tint of the discoloration, the relative rapidity of onset of this symptom, and the low dosage of thioridazine that was involved.
Get full access to this article
View all access options for this article.
References
1.
AppelbaumA., An Opthalmoscopic Study of Patients Under Treatment with Thioridazine, Arch. Opthalmol., 69, pp. 578–580, 1963.
2.
MorisonS. B., Transient Visual Symptoms Associated with Mellaril Medication, Am. J. Psychiat., 116, pp. 1032–1033, 1970.
3.
CameronM. E.LawrenceJ. M.OlrichJ. G., Thioridazine Retinopathy, Br. J. Opthalmol., 56, pp. 131–133, 1972.
4.
GianniniA. J.BlackH., Psychiatric, Psychogenic, and Somatopsychic Disorders Handbook, Medical Examination Publishing/Excerpta Medica, Garden City, New York, p. 30, 1978.
5.
HagopianV.StrattonD. B.BusickR. D., Five Cases of Pigmentary Retinopathy Associated with Thioridazine Administration, Am. J. Psychiat., 123, pp. 97–100, 1966.
6.
ScottA. W., Retinal Pigmentation in a Patient Receiving Thioridazine, Arch. Opthalmol., 70, pp. 775–778, 1967.
7.
DavidorfF. M., Thioridazine Pigmentary Retinopathy, Arch. Opthalmol., 90, pp. 251–255, 1973.
8.
GregoryM. H.RuttyD. A.WoodR. D., Differences in the Retinotoxic Action of Chloroquine and Phenothiazine Derivatives, J. Pathol., 102, pp. 139–145, 1970.
9.
CerlettiA.Meier-RugeW., Toxicological Studies on Phenothiazine Induced Retinopathy, Proc. European Study of Drug Toxicity, Excerpts Medica Foundation, Amsterdam, pp. 170–182, 1968.
10.
BernsteinH. N.GinsbergJ., The Pathology of Chloroquin Retinopathy, Arch. Ophthalmol., 71, p. 238, 1964.
11.
EhringerB.NordenfeldtL., Destruction of Retinal Dopamine-Containing Neurons in Rabbit and Goldfish, Exp. Eye Res., 24, pp. 179–187, 1977.
12.
RubinM.SlonickA., A Mechanism for the Toxicity of Chloroquine, Arthritis Rheumnt., 9, p. 537, 1966.
13.
WeeklyR. D.PottsA. M.RebotonJ.MayR. H., Pigmentary Retinopathy in Patients Receiving High Doses of a New Phenothiazine, Arch. Ophthalmol., 64, p. 65, 1960.